MedTrace Logo

Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction

NCT02496845 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-07-15

No results posted yet for this study

Summary

VL#FIA3-30 is a preparation intended for topical use, applied on the penis, for the treatment of ED.

Conditions

Interventions

DRUG

VL#FIA3-30

Vasoactive dual treatment (MH30-01 \& IS045-01)

Sponsors & Collaborators

  • VasoLead (2012) Ltd.

    lead OTHER

Principal Investigators

  • Gruenwald Ilan, Prof. · Rambam Health Care Campus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2015-11-30
Completion
2016-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02496845 on ClinicalTrials.gov